Clindamicin phosphate
RxNorm 797272
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 797272 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Clindamicin phosphate.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Clindamicin phosphate
(Atom ID: 399882)
PINPrescribable
Precise Ingredient (PIN):
Clindamycin phosphate
(Atom ID: 3500918)
PTPrescribable
Designated preferred name (PT):
Clindamycin phosphate
(Atom ID: 399873)
FNPrescribable
Full form of descriptor (FN):
Clindamycin phosphate (substance)
(Atom ID: 399883)
Patient Education
Clindamycin Topical
Topical clindamycin is used to treat acne. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria that cause acne and by decreasing swelling.
[Learn More]
Clindamycin and Benzoyl Peroxide Topical
The combination of clindamycin and benzoyl peroxide is used to treat acne. Clindamycin and benzoyl peroxide are in a class of medications called topical antibiotics. The combination of clindamycin and benzoyl peroxide works by killing the bacteria that cause acne.
[Learn More]
Tretinoin Topical
Tretinoin (Altreno, Atralin, Avita, Retin-A) is used to treat acne. Tretinoin is also used to reduce fine wrinkles (Refissa and Renova) and to improve spotty discoloration (Renova) and rough feeling skin (Renova) when used along with other skin care and sunlight avoidance programs. Tretinoin is in a class of medications called retinoids. It works by promoting peeling of affected skin areas and unclogging pores.
[Learn More]
* Please review the disclaimer below.